Research Unit for Dietary Studies at The Parker Institute, Bispebjerg and Frederiksberg Hospital, Part of the Copenhagen University Hospital, The Capital Region, Nordre Fasanvej 57, Vej 8, Indgang 11, 2000 Frederiksberg, Denmark.
Hans Christian Andersen Children's Hospital, Odense University Hospital, 5000 Odense, Denmark.
Nutrients. 2023 Apr 28;15(9):2125. doi: 10.3390/nu15092125.
Maternal dietary factors have been suggested as possible contributing influences for congenital anomalies (CAs). We aimed to assess the association between vitamin D supplementation or vitamin D status (s-25OHD) during pregnancy and CAs in the offspring. A comprehensive literature search was conducted in the three electronic databases: PubMed, Embase, and Cochrane Library. Included studies were critically appraised using appropriate tools (risk of bias 2, ROBINS-I). A protocol was registered in the International Prospective Register of Systematic Reviews (CRD42019127131). A meta-analysis of four randomised controlled trials (RCTs) including 3931 participants showed no effect of vitamin D supplementation on CAs, a relative risk of 0.76 (95% CI 0.45; 1.30), with moderate certainty in the effect estimates by GRADE assessment. Of the nine identified observational studies, six were excluded due to a critical risk of bias in accordance with ROBINS-I. Among the included observational studies, two studies found no association, whereas one case-control study identified an association between s-25OHD < 20 nmol/L and neural tube defects, with an adjusted odds ratio of 2.34 (95% CI: 1.07; 5.07). Interpretation of the results should be cautious given the low prevalence of CAs, RCTs with onset of supplementation after organogenesis, and low-quality observational studies.
母体膳食因素被认为是导致先天畸形(CAs)的可能影响因素之一。我们旨在评估孕妇补充维生素 D 或维生素 D 状态(s-25OHD)与后代 CAs 之间的关联。在三个电子数据库:PubMed、Embase 和 Cochrane Library 中进行了全面的文献检索。使用适当的工具(风险偏倚 2,ROBINS-I)对纳入的研究进行了批判性评估。该方案已在国际前瞻性系统评价注册库(CRD42019127131)中进行了注册。四项随机对照试验(RCT)的荟萃分析包括 3931 名参与者,结果表明维生素 D 补充剂对 CAs 没有影响,相对风险为 0.76(95% CI 0.45;1.30),GRADE 评估的效果估计具有中等确定性。在确定的 9 项观察性研究中,有 6 项由于 ROBINS-I 存在严重的偏倚风险而被排除在外。在纳入的观察性研究中,有两项研究未发现关联,而一项病例对照研究发现 s-25OHD < 20 nmol/L 与神经管缺陷之间存在关联,调整后的优势比为 2.34(95% CI:1.07;5.07)。鉴于 CAs 的患病率较低、补充起始于器官发生后的 RCT 以及低质量的观察性研究,结果的解释应谨慎。